Status:
COMPLETED
Survival Expectations and Hope Among Cancer Patients at End-of-Life
Lead Sponsor:
Duke-NUS Graduate Medical School
Collaborating Sponsors:
National Cancer Centre, Singapore
National University Hospital, Singapore
Conditions:
Advanced Cancer
Eligibility:
All Genders
21+ years
Brief Summary
Literature shows that less than half of advanced cancer patients accurately understand their prognosis, with most being overly optimistic. Investigators suspect that many patients are reporting not wh...
Detailed Description
Cancer burden is increasing in Singapore. As Singapore's population increases, so too does the incidence of cancer. A total of 61,519 incident cancer cases were diagnosed in Singapore between 2010-201...
Eligibility Criteria
Inclusion
- The inclusion criteria for patients are:
- Age ≥ 21 years old
- Singaporean/Singapore Permanent Resident (PR)
- Diagnosed with advanced cancer by the primary physician
- Prognosis of ≤ 1 year as determined by the primary treating oncologist responding "YES" to the question "Do you believe that there is a high chance (greater than 50%) that this patient is unlikely to be alive in 12 months?" Only patients for whom the physicians respond as "YES" will be approached to participate in the study
Exclusion
- Patients deemed to be mentally incompetent and those not aware of their diagnosis.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT03325218
Start Date
April 1 2018
End Date
March 31 2022
Last Update
February 6 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore General Hospital
Singapore, Singapore, Singapore, 169608
2
National Cancer Centre Singapore
Singapore, Singapore, Singapore, 169610